Advisory Services Network, LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 179 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Advisory Services Network, LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$39,532
+6.3%
4,740
+46.3%
0.00%0.0%
Q4 2022$37,195
-51.7%
3,240
-33.2%
0.00%
-50.0%
Q2 2021$77,000
+83.3%
4,850
-14.9%
0.00%0.0%
Q4 2020$42,000
+110.0%
5,7000.0%0.00%
+100.0%
Q3 2020$20,000
+81.8%
5,7000.0%0.00%0.0%
Q1 2020$11,000
-45.0%
5,7000.0%0.00%0.0%
Q4 2019$20,000
+33.3%
5,700
+42.5%
0.00%0.0%
Q3 2019$15,0000.0%4,0000.0%0.00%0.0%
Q2 2019$15,000
-54.5%
4,0000.0%0.00%
-50.0%
Q1 2019$33,000
+3.1%
4,0000.0%0.00%
-33.3%
Q4 2018$32,000
-5.9%
4,000
-11.1%
0.00%
+50.0%
Q3 2018$34,000
+30.8%
4,5000.0%0.00%0.0%
Q2 2018$26,000
-16.1%
4,500
-30.8%
0.00%0.0%
Q1 2018$31,000
-3.1%
6,5000.0%0.00%
-33.3%
Q4 2017$32,000
-5.9%
6,5000.0%0.00%
-25.0%
Q3 2017$34,000
-5.6%
6,5000.0%0.00%
-20.0%
Q2 2017$36,000
-34.5%
6,5000.0%0.01%
-37.5%
Q1 2017$55,000
+77.4%
6,500
-7.1%
0.01%
+33.3%
Q3 2016$31,000
+3.3%
7,000
-33.3%
0.01%
-14.3%
Q2 2016$30,000
+76.5%
10,500
+78.0%
0.01%
+40.0%
Q1 2016$17,000
-84.0%
5,900
-19.2%
0.01%
-83.9%
Q2 2015$106,000
-73.1%
7,303
-76.4%
0.03%
-81.4%
Q2 2014$394,000
+567.8%
30,903
+299.7%
0.17%
+456.7%
Q4 2013$59,0007,7320.03%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Burrage Capital Management LLC 1,105,673$8,237,0006.28%
Sarissa Capital Management LP 8,175,000$60,903,0006.22%
ORACLE INVESTMENT MANAGEMENT INC 2,980,870$22,207,0002.78%
DG Capital Management, LLC 1,075,732$8,014,0001.70%
Ghost Tree Capital, LLC 900,000$6,705,0001.49%
Parkman Healthcare Partners LLC 538,370$4,011,0001.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,835,810$43,477,0000.86%
Formidable Asset Management, LLC 470,419$3,470,0000.80%
KNOTT DAVID M 219,461$1,635,0000.74%
Altium Capital Management LP 250,000$1,863,0000.70%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders